J. Redman

Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study

I. Ellis, S. Chin, C. Caldas, 2018, The lancet. Gastroenterology & hepatology.

Genomic profiling of acute myeloid leukaemia associated with ataxia telangiectasia identifies a complex karyotype with wild‐type TP53 and mutant KRAS, G3BP1 and IL7R

A. Taylor, S. Meyer, A. Larionov, 2020, Pediatric blood & cancer.

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.

Julie O. Culver, F. Couch, E. Goode, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Contribution of Germline Pathogenic Variants in Breast Cancer Genes to Contralateral Breast Cancer Risk in BRCA1/BRCA2/PALB2-Negative Women

D. Conti, P. Concannon, J. Bernstein, 2023, Cancers.

A biomarker panel predicts progression of Barrett's esophagus to esophageal adenocarcinoma.

R. Fitzgerald, J. Bergman, S. Meijer, 2018, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

PO-061 Exploring heritable predisposition to paediatric rhabdomyosarcomas

N. Coleman, A. Larionov, J. Scarth, 2018, ESMO Open.

MALTA (MYH9 ASSOCIATED ELASTIN AGGREGATION) SYNDROME: GERMLINE VARIANTS IN MYH9 CAUSE RARE SWEAT DUCT PROLIFERATIONS AND IRREGULAR ELASTIN AGGREGATIONS.

H. Firth, D. Adams, M. Ziemer, 2019, Journal of Investigative Dermatology.

The Discovery and Validation of Biomarkers for the Diagnosis of Esophageal Squamous Dysplasia and Squamous Cell Carcinoma

L. Wernisch, S. Dawsey, R. Fitzgerald, 2016, Cancer Prevention Research.